The global Exosomes Market size is projected to reach USD 794.2 million by 2030, registering a CAGR of 28.38% over the forecast period, according to a new report by Grand View Research, Inc. The major factors driving the market include technological advancements in exosome isolation and analytical procedures, growth in government and non-government initiatives for exosome research, and the increasing prevalence of cancer. For instance, according to the World Health Organization (WHO), in 2020 there were about 10 million deaths due to cancer, making it one of the foremost causes of death worldwide. The industry is anticipated to witness rapid growth, owing to the factors, such as the growing need for the identification of cancer biomarkers, detection of infectious agents, and discovery of treatment options for neurodegenerative & Cardiovascular Diseases (CVDs).
Exosomes released
by cells into body fluids display different RNA, protein, and lipid contents in
patients with various disease conditions as compared to healthy individuals.
Hence, exosomes can be used for the development of diagnostic procedures using
biomarker identification. The rising demand for fast, accurate, and minimally
invasive diagnostic procedures, thus, represents a promising opportunity for
the growth of exosome applications. The COVID-19 pandemic led to the disruption
of clinical trials investigating the diagnostic and therapeutic potential of
exosomes in 2020. In addition, nationwide lockdown restrictions, disruption of
supply chains, and diversion of investments toward COVID-19-related products
led to a decrease in the research and development activities involving
exosomes.
Despite the
adverse impact in 2020, the pandemic has opened up several new prospects for
the development of COVID-19 vaccines and treatments with the use of exosomes,
which, in turn, is expected to boost industry growth over the coming years. For
instance, in March 2021, Cell Guidance Systems, a U.S.-based biotechnology
research organization, announced plans for the development of exosome
therapeutics for treating COVID-19 disease. Moreover, growth in government and
non-government initiatives for exosome research is likely to drive the growth
during the study period. For instance, in Jan 2023, Mantra Bio raised funding
of USD 9 million to advance the development of its lead-targeted exosome
therapeutics program.
Similarly, in February
2021, Evox Therapeutics raised a funding of USD 95.18 million to advance the
exosome therapeutics and expand the company’s leading exome platform DeliverEX
globally. However, stringent regulations pertaining to the approval and
commercialization of exosome products may hamper the growth of the industry
over the forecast period. In addition, technical difficulties associated with
the implementation of exosomes in various applications may hamper the growth
during the study period. Some of the major challenges include the lack of
efficient transfection strategies and the need for optimization of purification
methods. Such, challenges are anticipated to impede the market growth.
List Of Key
Players in the Exosomes Market
- Danaher Corporation
- Hologic Inc.
- Fujifilm Holdings Corporation
- Lonza
- Miltenyi Biotec
- Bio-Techne Corporation
- QIAGEN
- Thermo Fisher Scientific, Inc.
- Abcam plc
- RoosterBio, Inc.
Related Press Release@ Exosomes Market Report
Exosomes Market
Report Highlights
- The kits & reagents segment held the largest
revenue share in 2023. Isolation of extracellular vesicles can be
difficult, non-specific, and a tedious process. Hence, key players are
launching innovative kits and reagents to broaden the applications of
exosomes, which is fueling the segment growth
- By workflow, the downstream analysis segment
accounted for the largest share in 2023. Major players are offering
various technologically advanced products for increasing the utility of
downstream analyses, which can positively affect the segment growth
- The cancer application segment dominated the market
in 2023 due to the broad range of applications of exosomes in cancer
diagnosis, prognosis, and treatment
- The pharmaceutical & biotechnology companies
end-use led industry in 2023 due to a rise in the R&D activities
- North America was the dominant region in 2023 due to
the presence of key players, rising government funding for the detection
of new biomarkers, and high incidence of chronic conditions
Exosomes Market Report Scope
|
Report Attribute |
Details |
|
Market
size value in 2024 |
USD 177.4
million |
|
Revenue
forecast in 2030 |
USD 794.2
million |
|
Growth
rate |
CAGR of
28.38% from 2024 to 2030 |
|
Actual
data |
2018 - 2023 |
|
Forecast period |
2024 - 2030 |
Exosomes Market
Segmentation
Grand View
Research has segmented the global exosomes market based on product &
Service, workflow, application, end-use, and region:
Exosomes Product
& Service Outlook (Revenue, USD Million, 2018 - 2030)
- Kits & Reagents
- Instruments
- Services
Exosomes Workflow
Outlook (Revenue, USD Million, 2018 - 2030)
- Isolation Methods
- Ultracentrifugation
- Immunocapture on Beads
- Precipitation
- Filtration
- Others
- Downstream analysis
- Cell Surface Marker Analysis using Flow Cytometry
- Protein Analysis using Blotting & ELISA
- RNA Analysis with NGS & PCR
- Proteomic Analysis using Mass Spectroscopy
- Others
Exosomes
Application Outlook (Revenue, USD Million, 2018 - 2030)
- Cancer
- Neurodegenerative Diseases
- Cardiovascular Diseases
- Infectious Diseases
- Others
Exosomes End Use
Outlook (Revenue, USD Million, 2018 - 2030)
- Pharmaceutical & Biotechnology Companies
- Hospitals & Diagnostics Centers
- Academic & Research Institutes
Exosomes Regional
Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
- Singapore
- Latin America
- Brazil
- Argentina
- MEA
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Explore Horizon, the world's most expansive market
research database
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment